Structure

InChI Key UIIMBOGNXHQVGW-UHFFFAOYSA-M
Smile O=C([O-])O.[Na+]
InChI
InChI=1S/CH2O3.Na/c2-1(3)4;/h(H2,2,3,4);/q;+1/p-1

Physicochemical Descriptors

Property Name Value
Molecular Formula CHNaO3
Molecular Weight 84.01
AlogP None
Hydrogen Bond Acceptor None
Hydrogen Bond Donor None
Number of Rotational Bond None
Polar Surface Area None
Molecular species None
Aromatic Rings None
Heavy Atoms None

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Oropharyngeal Neoplasms 3 D009959 ClinicalTrials
Renal Insufficiency, Chronic 3 D051436 ClinicalTrials
Acute Kidney Injury 3 D058186 ClinicalTrials
Acidosis 3 D000138 ClinicalTrials
Pulpitis 3 D011671 ClinicalTrials
Kidney Diseases 3 D007674 ClinicalTrials
Constipation 3 D003248 ClinicalTrials
Gastrointestinal Hemorrhage 3 D006471 ClinicalTrials
Renal Insufficiency 3 D051437 ClinicalTrials
Acute Kidney Injury 3 D058186 ClinicalTrials
Severe Acute Respiratory Syndrome 3 D045169 ClinicalTrials
Tension-Type Headache 2 D018781 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Heart Diseases 2 D006331 ClinicalTrials
Uterine Cervical Dysplasia 2 D002578 ClinicalTrials
Urinary Incontinence 2 D014549 ClinicalTrials
Hematologic Diseases 2 D006402 ClinicalTrials
Pancreatic Neoplasms 1 D010190 ClinicalTrials
HIV Infections 1 D015658 ClinicalTrials
Cystic Fibrosis 1 D003550 ClinicalTrials
Wounds and Injuries 1 D014947 ClinicalTrials
Pneumonia 0 D011014 ClinicalTrials
Brain Edema 0 D001929 ClinicalTrials
Kidney Calculi 0 D007669 ClinicalTrials
Stomach Neoplasms 0 D013274 ClinicalTrials

Related Entries

Mixture
Mixture
Mixture
Mixture
Mixture
Mixture
Mixture
Mixture
Mixture
Mixture
Mixture
Mixture
Mixture
Mixture
Mixture

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Injury, poisoning and procedural complications
17.61
General disorders and administration site conditions
14.93
Product issues
8.84
Cardiac disorders
7.25
Nervous system disorders
7.1
Vascular disorders
5.36
Infections and infestations
4.93
Gastrointestinal disorders
4.49
Skin and subcutaneous tissue disorders
4.49
Respiratory, thoracic and mediastinal disorders
4.06
Renal and urinary disorders
3.62
Psychiatric disorders
3.33
Immune system disorders
3.26
Metabolism and nutrition disorders
3.19
Investigations
2.32

Cross References

Resources Reference
CAS NUMBER 144-55-8
ChEBI 32139
ChEMBL CHEMBL1353
DrugBank DB01390
EPA CompTox DTXSID9021269
FDA SRS 8MDF5V39QO
KEGG C12603
PharmGKB PA451375
PubChem 516892
SureChEMBL SCHEMBL83